Merck & Co., Inc. (NYSE:MRK – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Wednesday. A number of other research analysts also recently weighed in on MRK. Truist Financial upped their price target on Merck […]